Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis-Reference-Cited by-同舟云学术

Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis

Published:1998-05 Issue:1 Volume:85 Page:78-86
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Katz-Levy Yael,Dayan Molly,Wirguin Itzhak,Fridkin Mati,Sela Michael,Mozes Edna

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference40 articles.

1. Analysis of the biological functions and fine specificity of (T,G)-A—L specific T cell clones;Axelrod;Immunobiology,1986

2. Experimental myathenia gravis—a murine system;Berman;J. Exp. Med.,1980

3. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes;Brocke;J. Clin. Invest.,1988

4. The autoimmune response of different mouse strains to T cell epitopes of the human acetylcholine receptor alpha subunit;Brocke;Immunology,1990

5. Lymphocyte activation in experimental autoimmune myasthenia gravis;de Baets;J. Immunol.,1982

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapies for the Treatment of Autoimmune Myasthenia Gravis;Clinical Applications of Immunomics;2008-07-31

2. The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand;Proceedings of the National Academy of Sciences;2007-10-23

3. Immunomodulatory Vaccines Against Autoimmune Diseases;Rejuvenation Research;2006-03

4. Treating autoimmune diseases through restoration of antigen-specific immune tolerance;Archivum Immunologiae et Therapiae Experimentalis;2006-01-23

5. Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells;Proceedings of the National Academy of Sciences;2005-07-12